LZTFL1 variants have been widely identified as a genetic risk factor for severe COVID-19 via a mechanism that could involve enhanced signaling of the epithelial–mesenchymal transition in pulmonary epithelial cells [42]. This evidence concerns the gene LZTFL1 and COVID-19.